UniProt ID | C4BPB_HUMAN | |
---|---|---|
UniProt AC | P20851 | |
Protein Name | C4b-binding protein beta chain | |
Gene Name | C4BPB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 252 | |
Subcellular Localization | Secreted. | |
Protein Description | Controls the classical pathway of complement activation. It binds as a cofactor to C3b/C4b inactivator (C3bINA), which then hydrolyzes the complement fragment C4b. It also accelerates the degradation of the C4bC2a complex (C3 convertase) by dissociating the complement fragment C2a. It also interacts with anticoagulant protein S and with serum amyloid P component. The beta chain binds protein S.. | |
Protein Sequence | MFFWCACCLMVAWRVSASDAEHCPELPPVDNSIFVAKEVEGQILGTYVCIKGYHLVGKKTLFCNASKEWDNTTTECRLGHCPDPVLVNGEFSSSGPVNVSDKITFMCNDHYILKGSNRSQCLEDHTWAPPFPICKSRDCDPPGNPVHGYFEGNNFTLGSTISYYCEDRYYLVGVQEQQCVDGEWSSALPVCKLIQEAPKPECEKALLAFQESKNLCEAMENFMQQLKESGMTMEELKYSLELKKAELKAKLL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
57 | Ubiquitination | IKGYHLVGKKTLFCN EECEEEECCEEEEEC | 31.91 | 22817900 | |
58 | Ubiquitination | KGYHLVGKKTLFCNA ECEEEECCEEEEECC | 34.80 | 21963094 | |
59 | Ubiquitination | GYHLVGKKTLFCNAS CEEEECCEEEEECCC | 44.52 | 21963094 | |
64 | N-linked_Glycosylation | GKKTLFCNASKEWDN CCEEEEECCCCCCCC | 39.66 | 18638581 | |
64 | N-linked_Glycosylation | GKKTLFCNASKEWDN CCEEEEECCCCCCCC | 39.66 | 16335952 | |
66 | Ubiquitination | KTLFCNASKEWDNTT EEEEECCCCCCCCCC | 19.67 | 21963094 | |
67 | Ubiquitination | TLFCNASKEWDNTTT EEEECCCCCCCCCCC | 61.49 | 21963094 | |
71 | N-linked_Glycosylation | NASKEWDNTTTECRL CCCCCCCCCCCEEEC | 40.16 | 14760718 | |
71 | N-linked_Glycosylation | NASKEWDNTTTECRL CCCCCCCCCCCEEEC | 40.16 | 18638581 | |
98 | N-linked_Glycosylation | FSSSGPVNVSDKITF ECCCCCCCCCCEEEE | 30.61 | 16335952 | |
98 | N-linked_Glycosylation | FSSSGPVNVSDKITF ECCCCCCCCCCEEEE | 30.61 | 18638581 | |
101 | Ubiquitination | SGPVNVSDKITFMCN CCCCCCCCEEEEEEC | 41.93 | 21963094 | |
102 | Ubiquitination | GPVNVSDKITFMCND CCCCCCCEEEEEECC | 35.82 | 21963094 | |
113 | Ubiquitination | MCNDHYILKGSNRSQ EECCEEEECCCCHHH | 3.97 | 21963094 | |
114 | Ubiquitination | CNDHYILKGSNRSQC ECCEEEECCCCHHHH | 51.22 | 21963094 | |
117 | N-linked_Glycosylation | HYILKGSNRSQCLED EEEECCCCHHHHCCC | 57.18 | UniProtKB CARBOHYD | |
134 | Ubiquitination | WAPPFPICKSRDCDP CCCCCCEECCCCCCC | 3.13 | 21963094 | |
135 | Ubiquitination | APPFPICKSRDCDPP CCCCCEECCCCCCCC | 49.60 | 21963094 | |
154 | N-linked_Glycosylation | HGYFEGNNFTLGSTI CEEEECCCEECCCEE | 41.98 | UniProtKB CARBOHYD | |
160 | O-linked_Glycosylation | NNFTLGSTISYYCED CCEECCCEEEEEECC | 16.49 | OGP | |
191 | Ubiquitination | WSSALPVCKLIQEAP HHHHHHHHHHHHHCC | 2.54 | 21963094 | |
192 | Ubiquitination | SSALPVCKLIQEAPK HHHHHHHHHHHHCCC | 49.19 | 21963094 | |
198 | Ubiquitination | CKLIQEAPKPECEKA HHHHHHCCCHHHHHH | 52.56 | 21963094 | |
199 | Ubiquitination | KLIQEAPKPECEKAL HHHHHCCCHHHHHHH | 61.57 | 21963094 | |
203 | Ubiquitination | EAPKPECEKALLAFQ HCCCHHHHHHHHHHH | 39.44 | 21963094 | |
204 | Ubiquitination | APKPECEKALLAFQE CCCHHHHHHHHHHHH | 56.86 | 21963094 | |
226 | Ubiquitination | MENFMQQLKESGMTM HHHHHHHHHHCCCCH | 3.60 | 29967540 | |
227 | Ubiquitination | ENFMQQLKESGMTME HHHHHHHHHCCCCHH | 45.56 | 29967540 | |
236 | Ubiquitination | SGMTMEELKYSLELK CCCCHHHHHHHHHHH | 3.93 | 29967540 | |
237 | Ubiquitination | GMTMEELKYSLELKK CCCHHHHHHHHHHHH | 35.75 | 29967540 | |
239 | Phosphorylation | TMEELKYSLELKKAE CHHHHHHHHHHHHHH | 17.49 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of C4BPB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of C4BPB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of C4BPB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ZN655_HUMAN | ZNF655 | physical | 26186194 | |
DCTN4_HUMAN | DCTN4 | physical | 26186194 | |
PROS_HUMAN | PROS1 | physical | 26186194 | |
MTO1_HUMAN | MTO1 | physical | 26186194 | |
RTL8C_HUMAN | FAM127A | physical | 26186194 | |
VPS52_HUMAN | VPS52 | physical | 26186194 | |
GDC_HUMAN | SLC25A16 | physical | 26186194 | |
DCTN6_HUMAN | DCTN6 | physical | 26186194 | |
ORNT1_HUMAN | SLC25A15 | physical | 26186194 | |
KMCP1_HUMAN | SLC25A30 | physical | 26186194 | |
NEK4_HUMAN | NEK4 | physical | 26186194 | |
DCTN3_HUMAN | DCTN3 | physical | 26186194 | |
MP2K7_HUMAN | MAP2K7 | physical | 26186194 | |
ZN655_HUMAN | ZNF655 | physical | 28514442 | |
PROS_HUMAN | PROS1 | physical | 28514442 | |
RTL8C_HUMAN | FAM127A | physical | 28514442 | |
ORNT1_HUMAN | SLC25A15 | physical | 28514442 | |
VPS52_HUMAN | VPS52 | physical | 28514442 | |
MP2K7_HUMAN | MAP2K7 | physical | 28514442 | |
DCTN4_HUMAN | DCTN4 | physical | 28514442 | |
DCTN6_HUMAN | DCTN6 | physical | 28514442 | |
RM10_HUMAN | MRPL10 | physical | 28514442 | |
ACTY_HUMAN | ACTR1B | physical | 28514442 | |
NEK4_HUMAN | NEK4 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-98, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-64 AND ASN-98, AND MASSSPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-64; ASN-71 AND ASN-98, ANDMASS SPECTROMETRY. |